The risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data

Similar documents
MRI carotid plaque imaging predicts future stroke in patients with mild to moderate stenosis ICAD study

Spontaneous embolisation on TCD and carotid plaque features

Morphological duplex ultrasound criteria how to assess and report echolucency, inhomogeneity and ulceration

Plaque protrusion during carotid artery stenting: risk factors determined by MR plaque imaging

3D-Black-Blood 3T-MRI for the Diagnosis of thoracic large Vessel Vasculitis: A Feasibility Study

Carotid Plaque MRI and Stroke Risk A Systematic Review and Meta-analysis

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Thrombectomy with the preset stent-retriever. Insights from the ARTESp* trial

Massimiliano Fusaro, MD on behalf of ISAR-STATH Investigators. Deutsches Herzzentrum München, Technische Universität München Munich - Germany

ICSS Safety Results NOT for PUBLICATION. June 2009 ICSS ICSS ICSS ICSS. International Carotid Stenting Study: Main Inclusion Criteria

a physician-initiated study investigating the RoadSaver stent in carotid lesions Dr. Michel Bosiers

Will guidelines and clinical practice for asymptomatic stenosis change in the near future?

Carotid Artery Stenosis

Advances in the treatment of posterior cerebral circulation symptomatic disease

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

Fractional Flow Reserve Guided PCI versus Medical Therapy in Stable Coronary Disease. FAME 2 Trial

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Carotid artery stenting for long CTO and pseudo occlusion of carotid artery -2 case reports-

Endovascular treatment for pseudoocclusion of the internal carotid artery

Carotid Endarterectomy vs. Carotid artery Stenting (Surgeon Perspective)

How good is current best medical therapy (BMT) for stroke prevention in patients with asymptomatic carotid stenosis?

Carotid stenosis management: CAS or CEA? Yaoguo Yang, Chen Zhong Beijing Anzhen Hospital,China

Is there enough evidence for DAPT after endovascular intervention for PAOD?

ORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis

PrOspective multicenter study of carotid artery stenting Usinng mer Stent OCEANUS study!!!

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

How to Choose Between Carotid Stenting and Carotid Endarterectomy for Stroke Prevention

Alma Mater Studiorum Università di Bologna

CVD risk assessment using risk scores in primary and secondary prevention

Tips and Tricks for CAS T-CAR

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Drug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience

Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

New ischemic brain lesions on DW-MRI after CAS with double layer stent

A common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report

For the ICSS Investigators. 7 th Munich Vascular Conference Munich, 7 December 2017

How Duplex Ultrasound Screening Can Lead to Overuse of Carotid Interventions. No Disclosures. Prevalence >70% Asymptomatic ICA Stenosis*

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

Liping Liu Dpet. of Neurology and Stroke Center Beijing Tiantan Hospital Capital Medical University

Internal carotid artery near-total occlusions: Is it justified to operate on them?

Disclosures. Dr. Scirica has also served as a consultant for Lexicon, Arena, Gilead, and Eisai.

Protokollanhang zur SPACE-2-Studie Neurology Quality Standards

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

The learning curve associated with intracranial angioplasty and stenting: analysis from a single center

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

ORIGINAL CONTRIBUTION. Early Stroke Risk After Transient Ischemic Attack Among Individuals With Symptomatic Intracranial Artery Stenosis

3-year results of the OLIVE registry:

CAROTID STENTING A 2009 UPDATE. Hoang Duong, MD Director of Interventional Neuroradiology Memorial Regional Hospital

Importance of Thorough Vessel Preparation Followed By Anti- Restenotic Therapy: An Update from the DEFINITIVE AR Study

From interventional cardiology to cardio-neurology. A new subspeciality

The New England Journal of Medicine PROGNOSIS AFTER TRANSIENT MONOCULAR BLINDNESS ASSOCIATED WITH CAROTID-ARTERY STENOSIS

CAROTID DEBATE High-Grade Asymptomatic Disease Should Be Repaired Selectively; Medical Management is NOT Enough

Usefulness of Plaque Magnetic Resonance Imaging in Identifying High-Risk Carotid Plaques Irrespective of the Degree of Stenosis

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion

MEET Θ symptomatic patients. K. Mathias Department of Radiology Teaching Hospital of Dortmund - Germany

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

The CARENET all-comer trial using the CGuard micronet covered carotid embolic prevention stent

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

PAPER F National Collaborating Centre for Chronic Conditions at the Royal College of Physicians

Critical Review Form Therapy

PFO Closure for the Management of Migraine and Stroke

Perioperative mortality, paraplegia, stroke and long-term stent related complications after TEVAR for traumatic thoracic aortic lesions

Managing Dyslipidemia in Disclosures. Learning Objectives 03/05/2018. Speaker Disclosures

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Predictors, incidence and outcomes of patients undergoing transcatheter aortic valve implantation complicated by stroke

Supplementary Online Content

The Great Swedish Debate. Håkan Pärsson Department Vascular Surgery Helsingborgs Lasarett, University Lund

Predictors of restenosis and cardiovascular events in patients undergoing percutaneous angioplasty for subclavian/innominate artery stenosis

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions

Algorithmic selection of emboli protection device during the procedure of carotid artery stunting

CEA or CAS for asymptomatic carotid stenosis which patients benefit most?

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Troponin I elevation increases the risk of death and stroke in patients with atrial fibrillation a RE-LY substudy. Ziad Hijazi, MD

Acute Stroke Management What is State of the Art?

BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

PREDICTORS OF PERI-PROCEDURAL OUTCOMES OF CAS A REAL WORLD EXPERIENCE

Carotid Artery Stenting

TIA SINGOLO E IN CRESCENDO: due diversi scenari della rivascolarizzazione urgente carotidea

Recurrent stroke risk is high after a single cerebrovascular event in patients with symptomatic 50-99% carotid stenosis: a cohort study

Therapy for Acute Stroke. Systems of Care for TIA

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Angioplasty Alone: May Be the Best Endovascular Treatment for ICAS

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

XPEDITE Clinical Study PaclitaXel-coated Peripheral StEnts used In the Treatment of FemoropoplitEal Stenoses

I, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

Transcription:

The risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke: a meta-analysis of individual patient data Schindler A 1, Bonati LH 2, Schinner R 1, Altaf N 3, Hosseini AA 3, Esposito-Bauer L 2,6, Singh N 5, Kwee R 7, Kurosaki Y 8, Yamagata S 8, Yoshida K 9, Miyamoto S 9, Maggisano R 5, Ricke J 1, Moody AR 5, Kooi ME 4, Auer DP 3, Poppert H 6, Saam T 1 1 Department of Radiology, University Hospital, Ludwig-Maximilians-University, Munich, Germany, 2 Stroke Center, Departments of Neurology and Clinical Research, University of Basel Hospital, Basel, Switzerland 3 Radiological Sciences, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK, 4 Department of Radiology, Maastricht University Medical Center, Maastricht, the Netherlands 5 Department of Diagnostic Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, 6 Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany 7 Department of Radiology, Zuyderland Medical Center, Heerlen, the Netherlands 8 Department of Neurosurgery, Kurashiki Central Hospital, Okayama, Japan 9 Department of Neurosurgery, Graduate school of Medicine, Kyoto University, Kyoto, Japan

DISCLOSURE Speaker name: Dr. med. Andreas Schindler I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest 2 10.12.2017

CLINICAL BACKGROUND Carotid intraplaque Hemorrhage (IPH): association with first-time and recurrent cerebrovascular symptoms MRI is ideally suited to visualize intraplaque hemorrhage with high correlation to histology 1 Cohort based meta-analyses 2,3,4 : ~5 12 fold increased risk for ipsilateral cerebrovascular events (stroke, TIA, amaurosis fugax) in vessels with IPH Limitations: Heterogeneity, combined study endpoints, lack of individual patient information (e.g. risk factors, degree of stenosis) 2 Gupta A et al., Stroke 2013 3 Hosseini AA, et al., Ann Neurol 2013 4 Saam T et al., JACC 2013 1 Cai JM et al., Circulation 2002 3 10.12.2017

CLINICAL BACKGROUND Current consensus 1 : use of ischemic stroke as sole outcome event in clinical / therapeutic studies Low number of stroke in individual MR-IPH based studies impedes precise risk estimates Pooling of individual patient data 2 Reasonable case numbers Adjustment for risk factors and degree of stenosis 1 Sacco RL et al., Stroke 2013 2 Drazen JM, N Engl J Med 2015 4 10.12.2017

STUDY AIM To estimate the precise risk of MR-detected carotid plaque hemorrhage on recurrent or first-time stroke during follow-up in previously symptomatic and asymptomatic patients in an individual patient based meta-analysis 5 10.12.2017

Included Eligibility Screening Identification LITERATURE RESEARCH / INCLUSION CRITERIA Potentially relevant articles identified through multiple database searching (n=2.363) 1.907 articles screened 69 Full-text articles assessed for eligibility 13 Studies eligible for inclusion; study investigators invited to share individual patient data 7 Studies included in qualitative synthesis and meta-analysis (n=722 subjects) 456 duplicates removed 1.838 articles excluded based on title and abstract review Full-text articles excluded based on full text review: 33 No follow-up provided / retrospective study design 9 overlapping study population 1 Number of IPH not provided ( Very low ) 1 IPH not diagnosed by fatsaturated T1w sequences 4 Carotid intervention or surgery 8 No cerebrovascular endpoints provided 6 Studies excluded because investigators did not provide individual patient data (563 patients): 4 studies from 2 centers; concerns with ethical issues 2 no response to invitation Inclusion criteria Studies containing 20 subjects Detailed assessment of IPH in the carotid arteries at baseline on a MRI scanner 1.5T Evaluation of carotid stenosis degree Clinical follow-up after carotid MRI Symptomatic pat. Asymptomatic indiv. (>50% NASCET) BL-MRI IPH? Survival analysis Multivariate analysis Institut für Klinische Radiologie Direktor: Prof. Dr. Dr. h.c. M. Reiser FACR FRCR Follow-up

Symptomatic (n=560) Asymptomatic with >50% stenosis (n=136) Age at baseline (years) 72.8 ± 9.7 73.4 ± 8.9 Male 386 (68.9%) 115 (84.6%) Diabetes mellitus 125 (22.3%) 31 (22.8%) Hypertension 370 (66.1%) 105 (77.2%) Any smoking (former or current) 270 (48.2%) 90 (66.2%) Type of Symptoms at time of inclusion stroke TIA retinal ischemia asymptomatic 285 (50.9%) 201 (35.9%) 74 (13.2%) - - - - 136 (100%) IPH in the baseline carotid MRI 289 (51.6%) 40 (29.4%) Stenosis < 50% 50 69% 70 99% Type of symptoms at event during follow-up stroke TIA retinal ischemia no event 187 (33.4%) 192 (34.3%) 181 (32.3%) 60 (10.7%) 42 (7.5%) 15 (2.7%) 443 (79.1%) - 128 (94.1%) 8 (5.9%) 6 (4.4%) 4 (2.9%) 0 (0%) 126 (92.6%) Time between qualifying event and MRI (days) 24.0 (8.0 47.0) - Duration of follow-up (months) 12.0 (2.9 21.2) 30.9 (18.9 40.5) Total: 1.121 patient years Time between inclusion and outcome event (months) 5.2 (1.1 17.7) 12.0 (4.8 17.5) 7 Data are mean±sd, median (IQR) or number (%). IPH=intra-plaque KLINIKUM hemorrhage. DER UNIVERSITÄT MÜNCHEN 10.12.2017 Institut für Klinische Radiologie Direktor: Prof. Dr. Dr. h.c. M. Reiser FACR FRCR

KAPLAN-MEIER PLOTS & CUMULATIVE RISK OF FUTURE STROKE EVENT Asymptomatic individuals (>50% stenosis) Symptomatic patients (all stenoses) 7.9 (95% CI 1.3 47.6) Hazard Ratio (unadjusted) 10.2 (4.6 22.5) Institut für Klinische Radiologie Direktor: Prof. Dr. Dr. h.c. M. Reiser FACR FRCR

ASSOCIATION OF IPH WITH FUTURE IPSILATERAL STROKE Symptomatic total < 50% 50-69% 70-99% Asymptomatic 50% Overall 9 10.12.2017

INFLUENCE OF CARDIOVSCULAR RISK-FACTOS ON THE OCCURENCE OF STROKE EVENTS Frailty model comparing stroke risk depending on baseline characteristics in all symptomatic patients. Participants (N) Hazard Ratio (95% CI) P-Value Age < 65 yrs* 65-74 yrs > 74 yrs 105 150 303 1.00 0.88 (0.37 2.07) 0.74 (0.33 1.66) 0.76 0.46 Sex Male* Female Diabetes mellitus no* yes Hypertension no* yes 384 174 1.05 (0.52 2.13) 0.89 125 189 1.73 (0.95 3.17) 0.07 189 369 1.09 (0.55 2.18) 0.8 Degree of stenosis < 50%* 50 69% 70 99% 186 191 181 1.00 2.00 (0.96 4.20) 3.37 (1.46 7.79) 0.066 0.004 Type of qualifying event Stroke* TIA Retinal ischaemia (incl. Retinal infarction and AmF) 284 200 74 1.00 1.1 (0.62 1.95) 0.36 (0.10 1.23) 0.75 0.10 IPH at inclusion no* yes * reference category 271 287 10.81 KLINIKUM (4.72 DER 24.76) UNIVERSITÄT < 0.001 MÜNCHEN Institut für Klinische Radiologie Direktor: Prof. Dr. Dr. h.c. M. Reiser FACR FRCR

CONCLUSION Presence of IPH increases the risk for future stroke ~8-fold in asymptomatic (>50% carotid stenosis) individuals, and ~10-fold in symptomatic patients among all stenosis categories. Among classical risk factors only the degree of stenosis significantly increases stroke risk, however, with clearly lower hazard ratios. Study results provide needed risk estimates for the planning of interventional / therapeutic studies. IPH-status should be recognized as additional criterion in future risk scores. Improve the selection of patients for the best treatment option

CONTRIBUTING CENTERS & WORK GROUPS Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany T Saam, ATR Schindler, R Schinner, J Ricke Stroke Center, Departments of Neurology and Clinical Research, University Hospital Basel, Basel, Switzerland LH Bonati Radiological Sciences, Division of Clinical Neuroscience and Department of Vascular Surgery, University of Nottingham, Nottingham, UK DP Auer, AA Hosseini, N Altaf Department of Radiology, Maastricht University Medical Center, Maastricht, the Netherlands ME Kooi, RM Kwee Department of Neurosurgery, The Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka, Japan Y Kurosaki Department of Neurosurgery, Kurashiki Central Hospital, Okayama, Japan S Yamagata, K Yoshida Department of Diagnostic Imaging, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada AR Moody, N Singh Department of Neurology, Technische Universität München, Munich, Germany L Esposito-Bauer, H Poppert THANK YOU